Nasdaq Faces Weekly Loss as Tech Stocks Slide
Technology stocks fell as investors reassessed AI spending, valuations, debt, oil prices, and economic growth, leaving the Nasdaq and S&P 500 headed for weekly losses.
Netflix Stock Falls After Content Leadership Shake-Up
Netflix shares fell about 2% after Peter Rice replaced Bela Bajaria as chief content officer, alongside a reported 1,000 job cuts before earnings.
Brent Oil Reaches $110 Amid Hormuz and Refinery Risks
Brent crude reached $110 as Iran-related risks around the Strait of Hormuz and Ukraine’s threats against Russian refineries raised concerns about crude and fuel supplies.
Why Apple Is Finally Building Smart-Home Devices
Apple is reportedly expanding into dedicated smart-home hardware and AI-powered Siri to strengthen Apple Home, improve reliability, and compete with Amazon and Google.
Apple Says Foldable iPhones Face Extraordinary Demand
Apple reportedly says extraordinary demand has driven foldable iPhone sellouts, while some delivery estimates extend into 2027 amid possible supply constraints.
Apple TV 4K and HomePod Mini Price Hikes Explained
The reported $299 Apple TV 4K price raises the bar for Apple’s smart-home lineup. Here is how to assess the new features, upgrade value, and alternatives.
Surface Laptop Ultra vs. MacBook Pro: Which Wins?
The Surface Laptop Ultra suits Windows users, gamers, and enterprise workflows. The MacBook Pro remains stronger for macOS efficiency, creative work, and Apple integration.
Is This Year’s Flu Vaccine a Good Match?
Flu activity is rising, but an imperfect vaccine match does not mean vaccination lacks value. Here is what current evidence can and cannot show.
Menopause Treatment: New Guidance on Hot Flashes and Sleep
Updated menopause guidance emphasizes individualized care for hot flashes, night sweats, insomnia, vaginal symptoms, and treatment risks.
L.A. County Reports First Cychlorphine-Linked Death
Los Angeles County has reported its first fatal overdose involving cychlorphine, a synthetic opioid described as more potent than fentanyl. Its prevalence remains unknown.